SETD2 and nonpapillary renal cell carcinoma: Supporting our findings, the analysis of these gene expression data set revealed that SETD2 should be considered as a favorable prognostic gene whereas ATG12 as an unfavorable prognostic gene for ccRCC patients (Fig. 8f, g).